ワクチンのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Vaccines Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16367 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のワクチンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のワクチンの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 ワクチン市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・組換えワクチン、ウイルスワクチン、多糖類ワクチン、その他 用途別セグメントは次のように区分されます。 ・狂犬病ワクチン、インフルエンザワクチン、HPVワクチン、B型肝炎、A型肝炎、らいワクチン、ポリオワクチン、JEワクチン、その他 世界のワクチン市場の主要な市場プレーヤーは以下のとおりです。 ・GSK、Sanofi、Merck、Pfizer、Novartis(GSK)、CSL、MedImmune LLC、J&J(Crucell)、China National Biotec、Tiantan、Hualan、Kangtai、Hissen、Jintan 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なワクチンメーカーの企業概要、2019年～2021年までのワクチンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別ワクチンの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのワクチン市場予測を収録しています。 ・第12、13、14章では、ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GSK、Sanofi、Merck、Pfizer、Novartis(GSK)、CSL、MedImmune LLC、J&J(Crucell)、China National Biotec、Tiantan、Hualan、Kangtai、Hissen、Jintan ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：組換えワクチン、ウイルスワクチン、多糖類ワクチン、その他 ・用途別分析2016年-2026年：狂犬病ワクチン、インフルエンザワクチン、HPVワクチン、B型肝炎、A型肝炎、らいワクチン、ポリオワクチン、JEワクチン、その他 ・ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Vaccines size is estimated to be XX million in 2021 from USD 43790 million in 2020, with a change of XX% between 2020 and 2021. The global Vaccines market size is expected to grow at a CAGR of 5.4% for the next five years.

Market segmentation
Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others

Market segment by Application can be divided into
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others

The key market players for global Vaccines market are listed below:
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccines, with price, sales, revenue and global market share of Vaccines from 2019 to 2021.
Chapter 3, the Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vaccines market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Global Vaccines Market Size & Forecast
1.4.1 Global Vaccines Sales in Value (2016-2026))
1.4.2 Global Vaccines Sales in Volume (2016-2026)
1.4.3 Global Vaccines Price by Type (2016-2026) & (US$/Pcs)
1.5 Global Vaccines Production Capacity Analysis
1.5.1 Global Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccines Market Drivers
1.6.2 Vaccines Market Restraints
1.6.3 Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Vaccines Product and Services
2.1.4 GSK Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Vaccines Product and Services
2.2.4 Sanofi Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Vaccines Product and Services
2.3.4 Merck Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Vaccines Product and Services
2.4.4 Pfizer Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Novartis(GSK)
2.5.1 Novartis(GSK) Details
2.5.2 Novartis(GSK) Major Business
2.5.3 Novartis(GSK) Vaccines Product and Services
2.5.4 Novartis(GSK) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 CSL
2.6.1 CSL Details
2.6.2 CSL Major Business
2.6.3 CSL Vaccines Product and Services
2.6.4 CSL Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 MedImmune LLC
2.7.1 MedImmune LLC Details
2.7.2 MedImmune LLC Major Business
2.7.3 MedImmune LLC Vaccines Product and Services
2.7.4 MedImmune LLC Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 J&J(Crucell)
2.8.1 J&J(Crucell) Details
2.8.2 J&J(Crucell) Major Business
2.8.3 J&J(Crucell) Vaccines Product and Services
2.8.4 J&J(Crucell) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 China National Biotec
2.9.1 China National Biotec Details
2.9.2 China National Biotec Major Business
2.9.3 China National Biotec Vaccines Product and Services
2.9.4 China National Biotec Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Tiantan
2.10.1 Tiantan Details
2.10.2 Tiantan Major Business
2.10.3 Tiantan Vaccines Product and Services
2.10.4 Tiantan Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Hualan
2.11.1 Hualan Details
2.11.2 Hualan Major Business
2.11.3 Hualan Vaccines Product and Services
2.11.4 Hualan Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Kangtai
2.12.1 Kangtai Details
2.12.2 Kangtai Major Business
2.12.3 Kangtai Vaccines Product and Services
2.12.4 Kangtai Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Hissen
2.13.1 Hissen Details
2.13.2 Hissen Major Business
2.13.3 Hissen Vaccines Product and Services
2.13.4 Hissen Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Jintan
2.14.1 Jintan Details
2.14.2 Jintan Major Business
2.14.3 Jintan Vaccines Product and Services
2.14.4 Jintan Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Vaccines Sales by Manufacturer
3.1 Global Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Vaccines Manufacturer Market Share
3.4.2 Top 6 Vaccines Manufacturer Market Share
3.5 Global Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vaccines Market Size by Region
4.1.1 Global Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Vaccines Revenue by Region (2016-2026)
4.2 North America Vaccines Revenue (2016-2026)
4.3 Europe Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Vaccines Revenue (2016-2026)
4.5 South America Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Vaccines Revenue by Type (2016-2026)
5.3 Global Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Vaccines Revenue by Application (2016-2026)
6.3 Global Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vaccines Sales by Type (2016-2026)
7.2 North America Vaccines Sales by Application (2016-2026)
7.3 North America Vaccines Market Size by Country
7.3.1 North America Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vaccines Sales by Type (2016-2026)
8.2 Europe Vaccines Sales by Application (2016-2026)
8.3 Europe Vaccines Market Size by Country
8.3.1 Europe Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Vaccines Market Size by Region
9.3.1 Asia-Pacific Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vaccines Sales by Type (2016-2026)
10.2 South America Vaccines Sales by Application (2016-2026)
10.3 South America Vaccines Market Size by Country
10.3.1 South America Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Vaccines Market Size by Country
11.3.1 Middle East & Africa Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vaccines Typical Distributors
12.3 Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Vaccines Product and Services
Table 6. GSK Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Vaccines Product and Services
Table 10. Sanofi Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Vaccines Product and Services
Table 14. Merck Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Vaccines Product and Services
Table 18. Pfizer Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis(GSK) Basic Information, Manufacturing Base and Competitors
Table 20. Novartis(GSK) Major Business
Table 21. Novartis(GSK) Vaccines Product and Services
Table 22. Novartis(GSK) Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. CSL Basic Information, Manufacturing Base and Competitors
Table 24. CSL Major Business
Table 25. CSL Vaccines Product and Services
Table 26. CSL Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 28. MedImmune LLC Major Business
Table 29. MedImmune LLC Vaccines Product and Services
Table 30. MedImmune LLC Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. J&J(Crucell) Basic Information, Manufacturing Base and Competitors
Table 32. J&J(Crucell) Major Business
Table 33. J&J(Crucell) Vaccines Product and Services
Table 34. J&J(Crucell) Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. China National Biotec Basic Information, Manufacturing Base and Competitors
Table 36. China National Biotec Major Business
Table 37. China National Biotec Vaccines Product and Services
Table 38. China National Biotec Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Tiantan Basic Information, Manufacturing Base and Competitors
Table 40. Tiantan Major Business
Table 41. Tiantan Vaccines Product and Services
Table 42. Tiantan Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hualan Basic Information, Manufacturing Base and Competitors
Table 44. Hualan Major Business
Table 45. Hualan Vaccines Product and Services
Table 46. Hualan Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Kangtai Basic Information, Manufacturing Base and Competitors
Table 48. Kangtai Major Business
Table 49. Kangtai Vaccines Product and Services
Table 50. Kangtai Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Hissen Basic Information, Manufacturing Base and Competitors
Table 52. Hissen Major Business
Table 53. Hissen Vaccines Product and Services
Table 54. Hissen Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Jintan Basic Information, Manufacturing Base and Competitors
Table 56. Jintan Major Business
Table 57. Jintan Vaccines Product and Services
Table 58. Jintan Vaccines Sales (K Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Vaccines Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 60. Global Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Vaccines Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 63. Head Office and Vaccines Production Site of Key Manufacturer
Table 64. Vaccines New Entrant and Capacity Expansion Plans
Table 65. Vaccines Mergers & Acquisitions in the Past Five Years
Table 66. Global Vaccines Sales by Region (2016-2021e) & (K Pcs)
Table 67. Global Vaccines Sales by Region (2021-2026) & (K Pcs)
Table 68. Global Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Vaccines Sales by Type (2016-2021e) & (K Pcs)
Table 71. Global Vaccines Sales by Type (2021-2026) & (K Pcs)
Table 72. Global Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Vaccines Price by Type (2016-2021e) & (US$/Pcs)
Table 75. Global Vaccines Price by Type (2021-2026) & (US$/Pcs)
Table 76. Global Vaccines Sales by Application (2016-2021e) & (K Pcs)
Table 77. Global Vaccines Sales by Application (2021-2026) & (K Pcs)
Table 78. Global Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Vaccines Price by Application (2016-2021e) & (US$/Pcs)
Table 81. Global Vaccines Price by Application (2021-2026) & (US$/Pcs)
Table 82. North America Vaccines Sales by Country (2016-2021e) & (K Pcs)
Table 83. North America Vaccines Sales by Country (2021-2026) & (K Pcs)
Table 84. North America Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Vaccines Sales by Type (2016-2021e) & (K Pcs)
Table 87. North America Vaccines Sales by Type (2021-2026) & (K Pcs)
Table 88. North America Vaccines Sales by Application (2016-2021e) & (K Pcs)
Table 89. North America Vaccines Sales by Application (2021-2026) & (K Pcs)
Table 90. Europe Vaccines Sales by Country (2016-2021e) & (K Pcs)
Table 91. Europe Vaccines Sales by Country (2021-2026) & (K Pcs)
Table 92. Europe Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Vaccines Sales by Type (2016-2021e) & (K Pcs)
Table 95. Europe Vaccines Sales by Type (2021-2026) & (K Pcs)
Table 96. Europe Vaccines Sales by Application (2016-2021e) & (K Pcs)
Table 97. Europe Vaccines Sales by Application (2021-2026) & (K Pcs)
Table 98. Asia-Pacific Vaccines Sales by Region (2016-2021e) & (K Pcs)
Table 99. Asia-Pacific Vaccines Sales by Region (2021-2026) & (K Pcs)
Table 100. Asia-Pacific Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Vaccines Sales by Type (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Vaccines Sales by Type (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Vaccines Sales by Application (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Vaccines Sales by Application (2021-2026) & (K Pcs)
Table 106. South America Vaccines Sales by Country (2016-2021e) & (K Pcs)
Table 107. South America Vaccines Sales by Country (2021-2026) & (K Pcs)
Table 108. South America Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Vaccines Sales by Type (2016-2021e) & (K Pcs)
Table 111. South America Vaccines Sales by Type (2021-2026) & (K Pcs)
Table 112. South America Vaccines Sales by Application (2016-2021e) & (K Pcs)
Table 113. South America Vaccines Sales by Application (2021-2026) & (K Pcs)
Table 114. Middle East & Africa Vaccines Sales by Country (2016-2021e) & (K Pcs)
Table 115. Middle East & Africa Vaccines Sales by Country (2021-2026) & (K Pcs)
Table 116. Middle East & Africa Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Vaccines Sales by Type (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Vaccines Sales by Type (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Vaccines Sales by Application (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Vaccines Sales by Application (2021-2026) & (K Pcs)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Vaccines Typical Distributors
Table 125. Vaccines Typical Customers
List of Figures
Figure 1. Vaccines Picture
Figure 2. Global Vaccines Sales Market Share by Type in 2020
Figure 3. Recombinant Vaccines
Figure 4. Viral Vaccines
Figure 5. Polysaccharide Vaccines
Figure 6. Others
Figure 7. Global Vaccines Sales Market Share by Application in 2020
Figure 8. Rabies vaccine
Figure 9. Influenza vaccine
Figure 10. HPV vaccine
Figure 11. Hepatitis B
Figure 12. Hepatitis A
Figure 13. Leprosy vaccine
Figure 14. Polio vaccine
Figure 15. JE vaccine
Figure 16. Others
Figure 17. Global Vaccines Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 18. Global Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 19. Global Vaccines Sales (2016-2026) & (K Pcs)
Figure 20. Global Vaccines Price by Type (2016-2026) & (US$/Pcs)
Figure 21. Global Vaccines Production Capacity (2016-2026) & (K Pcs)
Figure 22. Global Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 23. Vaccines Market Drivers
Figure 24. Vaccines Market Restraints
Figure 25. Vaccines Market Trends
Figure 26. Global Vaccines Sales Market Share by Manufacturer in 2020
Figure 27. Global Vaccines Revenue Market Share by Manufacturer in 2020
Figure 28. Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. Top 3 Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 30. Top 6 Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 31. Global Vaccines Sales Market Share by Region (2016-2026)
Figure 32. Global Vaccines Revenue Market Share by Region (2016-2026)
Figure 33. North America Vaccines Revenue (2016-2026) & (USD Million)
Figure 34. Europe Vaccines Revenue (2016-2026) & (USD Million)
Figure 35. Asia-Pacific Vaccines Revenue (2016-2026) & (USD Million)
Figure 36. South America Vaccines Revenue (2016-2026) & (USD Million)
Figure 37. Middle East & Africa Vaccines Revenue (2016-2026) & (USD Million)
Figure 38. Global Vaccines Sales Market Share by Type (2016-2026)
Figure 39. Global Vaccines Revenue Market Share by Type (2016-2026)
Figure 40. Global Vaccines Price by Type (2016-2026) & (US$/Pcs)
Figure 41. Global Vaccines Sales Market Share by Application (2016-2026)
Figure 42. Global Vaccines Revenue Market Share by Application (2016-2026)
Figure 43. Global Vaccines Price by Application (2016-2026) & (US$/Pcs)
Figure 44. North America Vaccines Sales Market Share by Type (2016-2026)
Figure 45. North America Vaccines Sales Market Share by Application (2016-2026)
Figure 46. North America Vaccines Sales Market Share by Country (2016-2026)
Figure 47. North America Vaccines Revenue Market Share by Country (2016-2026)
Figure 48. United States Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Vaccines Sales Market Share by Type (2016-2026)
Figure 52. Europe Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Europe Vaccines Sales Market Share by Country (2016-2026)
Figure 54. Europe Vaccines Revenue Market Share by Country (2016-2026)
Figure 55. Germany Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Vaccines Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Vaccines Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Vaccines Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Vaccines Revenue Market Share by Region (2016-2026)
Figure 64. China Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Korea Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Vaccines Sales Market Share by Type (2016-2026)
Figure 71. South America Vaccines Sales Market Share by Application (2016-2026)
Figure 72. South America Vaccines Sales Market Share by Country (2016-2026)
Figure 73. South America Vaccines Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East & Africa Vaccines Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Vaccines Sales Market Share by Application (2016-2026)
Figure 78. Middle East & Africa Vaccines Sales Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Vaccines Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Egypt Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. South Africa Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source

---